✦ LIBER ✦

CA 15-3 and CA 27-29 serum markers in monitoring breast cancer patients

✍ Scribed by S. Lauro; G. Lanzetta; L. Trasatti; F. Bordin; E. Bria; M.G. Reale; L. Frati

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

CA15-3, CASA, MSA, and TPS as diagnostic

✍ Peter L. Devine; Maree A. Duroux; Rachel J. Quin; Michael A. McGuckin; Gloria J. 📂 Article 📅 1995 🏛 Springer US 🌐 English ⚖ 566 KB

694 CA 15-3 tumor markers in detection o

✍ L. Maneva; N. Vasev; C. Toleska; Z. Atanasov 📂 Article 📅 1995 🏛 Elsevier Science 🌐 English ⚖ 139 KB

Monitoring different stages of breast ca

✍ G. Sölétormos; D. Nielsen; V. Schiøler; H. Mouridsen; P. Dombernowsky 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 133 KB

Clinical significance of a serum CA 15-3

✍ Shih-Chung Wu; Fong-Fu Chou; Kun-Ming Rau 📂 Article 📅 2010 🏛 Springer US 🌐 English ⚖ 129 KB

Clinical usefulness of CA 15-3 serum lev

✍ A. Farris; A.R. Casu; M. Piga; F. Dore; R. Eriu; M.G. Sarobba; G. Narras; T. Sed 📂 Article 📅 1987 🏛 Elsevier Science 🌐 English ⚖ 135 KB

680 CA 15-3 predicts outcome in breast c

✍ S.G. Shering; M.J. Duffy; E.W. McDermot; N.J. O’Higgins 📂 Article 📅 1995 🏛 Elsevier Science 🌐 English ⚖ 158 KB